Pulse Biosciences CS (PLSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 118,038 | 44,365 | 61,139 | 28,614 | 12,463 |
| Marketable Securities | N/A | N/A | N/A | N/A | 8,012 |
| Receivables | N/A | N/A | N/A | 61 | N/A |
| Inventories | N/A | N/A | N/A | 5,824 | 0 |
| TOTAL | $119,449 | $45,328 | $62,147 | $36,630 | $22,339 |
| Non-Current Assets | |||||
| PPE Net | 1,160 | 1,528 | 1,961 | 2,462 | 2,478 |
| Intangibles | 4,011 | 4,677 | 5,342 | 6,007 | 6,673 |
| Other Non-Current Assets | 7,840 | 7,621 | 8,427 | 9,150 | 9,803 |
| TOTAL | $13,011 | $13,826 | $15,730 | $17,619 | $18,954 |
| Total Assets | $132,460 | $59,154 | $77,877 | $54,249 | $41,293 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 917 | N/A | N/A |
| Accounts payable and accrued liabilities | 1,673 | 1,836 | 1,573 | 2,904 | 1,717 |
| Accrued Expenses | 7,027 | 3,814 | 2,595 | 4,389 | 5,326 |
| TOTAL | $10,055 | $6,708 | $5,981 | $8,519 | $7,585 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 65,000 | N/A | N/A |
| Deferred Revenues | N/A | N/A | N/A | 16 | N/A |
| Other Non-Current Liabilities | 7,543 | 8,086 | 9,144 | 10,040 | 10,814 |
| TOTAL | $7,543 | $8,086 | $74,144 | $10,040 | $10,814 |
| Total Liabilities | $17,598 | $14,794 | $80,125 | $18,559 | $18,399 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 67,274 | 55,225 | 37,593 | 29,802 | 26,087 |
| Common Shares | 66 | 55 | 37 | 29 | 25 |
| Retained earnings | -390,500 | -336,915 | -294,705 | -236,200 | -172,540 |
| Other shareholders' equity | 0 | 0 | 0 | 0 | -1 |
| TOTAL | $114,862 | $44,360 | $-2,248 | $35,690 | $22,894 |
| Total Liabilities And Equity | $132,460 | $59,154 | $77,877 | $54,249 | $41,293 |